Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA6 | P23280 | 2/20 | 0.31 |
| ▸ | CA5A | P35218 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | F13A1 | P00488 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | CASP2 | P42575 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5693369 | 0.95 | CA12 (0.32) | CA12CA2CA4CA6CA5A | |
| SCHEMBL7916836 | 0.86 | — | — | |
| SCHEMBL6933322 | 0.84 | — | — | |
| SCHEMBL28939437 | 0.78 | SCN2A (0.31) | — | |
| SCHEMBL7134159 | 0.78 | — | — | |
| SCHEMBL29185348 | 0.77 | — | — | |
| SCHEMBL28451905 | 0.76 | — | — | |
| SCHEMBL2465421 | 0.76 | SCN2A (0.33) | — | |
| SCHEMBL28807732 | 0.76 | SCN2A (0.33) | — | |
| SCHEMBL28330778 | 0.76 | SCN2A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3450532-B1 | USE OF AN AMODIMETHICONE/ORGANOSILICON-CONTAINING COPOLYMER, DETERGENT, USE OF THE DETERGENT AND WASHING METHOD | HENKEL AG & CO KGAA (DE) | 2022-05-04 | — | — | EP | claimed |
| EP-2207904-B1 | COATED LEATHER | LANXESS DEUTSCHLAND GMBH (DE) | 2014-02-12 | — | — | EP | claimed |
| EP-2207904-A2 | COATED LEATHER | Schaefer, Philipp (DE) | 2010-07-21 | — | — | EP | claimed |
| WO-2009049728-A2 | COATED LEATHER | SCHAEFER PHILIPP (DE) | 2009-04-23 | — | — | WO | claimed |
| EP-3450532-B1 | USE OF AN AMODIMETHICONE/ORGANOSILICON-CONTAINING COPOLYMER, DETERGENT, USE OF THE DETERGENT AND WASHING METHOD | HENKEL AG & CO KGAA (DE) | 2022-05-04 | — | — | EP | disclosed |
| EP-2711438-B1 | Coated leather | LANXESS DEUTSCHLAND GMBH (DE) | 2020-11-11 | — | — | EP | disclosed |
| US-10543156-B2 | Shaping keratin fibres using 2-oxazolidinone compounds | THE PROCTER & GAMBLE COMPANY (US) | 2020-01-28 | — | — | US | disclosed |
| EP-3256096-B1 | SHAPING KERATIN FIBRES USING ARABINOSE AND ETHYLENE CARBONATE | PROCTER & GAMBLE (US) | 2019-04-17 | — | — | EP | disclosed |
| US-10064799-B2 | Shaping keratin fibres using carbonate ester | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-04 | — | — | US | disclosed |
| EP-3310329-A1 | SHAPING KERATIN FIBRES USING 2-OXAZOLIDINONE COMPOUNDS | The Procter and Gamble Company (US) | 2018-04-25 | — | — | EP | disclosed |
| EP-3310325-A1 | SHAPING KERATIN FIBRES USING DIALDEHYDE COMPOUNDS | The Procter and Gamble Company (US) | 2018-04-25 | — | — | EP | disclosed |
| EP-3297731-A1 | SHAPING KERATIN FIBRES USING ARABINOSE AND ETHYLENE CARBONATE | The Procter and Gamble Company (US) | 2018-03-28 | — | — | EP | disclosed |
| WO-2015094760-A1 | SHAPING KERATIN FIBRES USING CARBONATE ESTER | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | disclosed |
| US-20150174037-A1 | SHAPING KERATIN FIBRES USING CARBONATE ESTER | THE PROCTER & GAMBLE COMPANY | 2015-06-25 | — | — | US | disclosed |
| EP-2711438-A2 | Coated leather | LANXESS Deutschland GmbH (DE) | 2014-03-26 | — | — | EP | disclosed |
| EP-2207904-B1 | COATED LEATHER | LANXESS DEUTSCHLAND GMBH (DE) | 2014-02-12 | — | — | EP | disclosed |
| EP-2105454-B1 | Thioether functionalised organopolysiloxanes | SCHILL & SEILACHER STRUKTOL GMBH (DE) | 2012-09-12 | — | — | EP | disclosed |
| EP-2207904-A2 | COATED LEATHER | Schaefer, Philipp (DE) | 2010-07-21 | — | — | EP | disclosed |
| EP-2105454-A1 | Thioether functionalised organopolysiloxanes | Schill + Seilacher "Struktol" Aktiengesellschaft (DE) | 2009-09-30 | — | — | EP | disclosed |
| WO-2009049728-A2 | COATED LEATHER | SCHAEFER PHILIPP (DE) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10543156-B2 | Shaping keratin fibres using 2-oxazolidinone compounds | KRT18, COL14A1, KIF5B | CA12 3449/4885CA2 3088/4885CA4 2547/4885 |
| US-10064799-B2 | Shaping keratin fibres using carbonate ester | KRT18, CKAP4, COL14A1 | CA12 206/4885CA2 237/4885CA4 126/4885 |
| US-20150174037-A1 | SHAPING KERATIN FIBRES USING CARBONATE ESTER | KRT18, CKAP4, COL14A1 | CA12 202/4885CA2 235/4885CA4 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.